Kuangli Photoelectric Technology Co Ltd (6431) - Total Assets
Based on the latest financial reports, Kuangli Photoelectric Technology Co Ltd (6431) holds total assets worth NT$1.19 Billion TWD (≈ $37.41 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 6431 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Kuangli Photoelectric Technology Co Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Kuangli Photoelectric Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore how much of Kuangli Photoelectric Technology Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Kuangli Photoelectric Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Kuangli Photoelectric Technology Co Ltd's total assets of NT$1.19 Billion consist of 39.1% current assets and 60.9% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 17.6% |
| Accounts Receivable | NT$82.33 Million | 6.9% |
| Inventory | NT$46.56 Million | 3.9% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$146.11 Million | 12.3% |
| Goodwill | NT$98.89 Million | 8.3% |
Asset Composition Trend (2012–2025)
This chart illustrates how Kuangli Photoelectric Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Kuangli Photoelectric Technology Co Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kuangli Photoelectric Technology Co Ltd's current assets represent 39.1% of total assets in 2025, a decrease from 63.6% in 2012.
- Cash Position: Cash and equivalents constituted 17.6% of total assets in 2025, down from 20.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is intangible assets at 12.3% of total assets.
Kuangli Photoelectric Technology Co Ltd Competitors by Total Assets
Key competitors of Kuangli Photoelectric Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
DR.Wu Skincare Co Ltd
TWO:6523
|
Taiwan | NT$1.59 Billion |
|
FN REPUBLIC Co. Ltd
KQ:064090
|
Korea | ₩76.50 Billion |
|
Mastrad
PA:ALMAS
|
France | €3.48 Million |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$154.64 Billion |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$6.01 Million |
|
Skin Elements Ltd
AU:SKN
|
Australia | AU$2.01 Million |
Kuangli Photoelectric Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 0.81 | 3.77 |
| Quick Ratio | 1.22 | 0.62 | 3.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$121.55 Million | NT$-58.75 Million | NT$131.77 Million |
Kuangli Photoelectric Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Kuangli Photoelectric Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.29 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 30.4% |
| Total Assets | NT$1.19 Billion |
| Market Capitalization | $59.38 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kuangli Photoelectric Technology Co Ltd's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Kuangli Photoelectric Technology Co Ltd's assets grew by 30.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kuangli Photoelectric Technology Co Ltd (2012–2025)
The table below shows the annual total assets of Kuangli Photoelectric Technology Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$1.19 Billion ≈ $37.41 Million |
+30.45% |
| 2024-12-31 | NT$910.20 Million ≈ $28.68 Million |
-12.75% |
| 2023-12-31 | NT$1.04 Billion ≈ $32.87 Million |
-6.48% |
| 2022-12-31 | NT$1.12 Billion ≈ $35.15 Million |
-10.69% |
| 2021-12-31 | NT$1.25 Billion ≈ $39.35 Million |
+230.46% |
| 2020-12-31 | NT$377.99 Million ≈ $11.91 Million |
-31.94% |
| 2019-12-31 | NT$555.40 Million ≈ $17.50 Million |
+24.35% |
| 2018-12-31 | NT$446.66 Million ≈ $14.07 Million |
-6.00% |
| 2017-12-31 | NT$475.20 Million ≈ $14.97 Million |
-28.69% |
| 2016-12-31 | NT$666.35 Million ≈ $20.99 Million |
-36.29% |
| 2015-12-31 | NT$1.05 Billion ≈ $32.95 Million |
-26.97% |
| 2014-12-31 | NT$1.43 Billion ≈ $45.12 Million |
+13.61% |
| 2013-12-31 | NT$1.26 Billion ≈ $39.71 Million |
+11.60% |
| 2012-12-31 | NT$1.13 Billion ≈ $35.59 Million |
-- |
About Kuangli Photoelectric Technology Co Ltd
Kuangli Bio-Tech Holdings Co., Ltd. manufactures and sells panels for cover lens used in various electronic products in Taiwan and China. The company's products are used in mobile phone, PDA, instrument panels, digital camera windows, medical equipment, etc. It also engages in research and development, manufacturing, and sale of related biotech products, such as cosmetic, skin care, and health fo… Read more